Medifast (MED) Receivables (2010 - 2021)

Medifast has reported Receivables for 12 years, with the latest figure at $88000.0 in Q1 2021.

• For the quarter ending Q1 2021, Receivables fell 77.44% year-over-year to $88000.0; the trailing twelve-month figure through Mar 2021 stood at $88000.0 (down 77.44% YoY), and the FY2020 full-year result was $584000.0, down 59.36% from the prior year.
• Receivables for Q1 2021 stood at $88000.0, down from $584000.0 in the prior quarter.
• The five-year high for Receivables was $1.5 million in Q1 2017, with the low at $88000.0 in Q1 2021.
• Historically, Receivables has averaged $865882.4 across 5 years, with a median of $914000.0 in 2017.
• Annual changes were most pronounced in 2018 — Receivables surged 75.52% — and 2021, when it tumbled 77.44%.
• Medifast's Receivables stood at $576000.0 in 2017, then soared by 75.52% to $1.0 million in 2018, then soared by 42.14% to $1.4 million in 2019, then plunged by 59.36% to $584000.0 in 2020, then tumbled by 84.93% to $88000.0 in 2021.
• The last three Receivables figures came in at $88000.0 (Q1 2021), $584000.0 (Q4 2020), and $647000.0 (Q3 2020), per Business Quant data.